270 related articles for article (PubMed ID: 25252941)
41. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
42. Transcription factors that regulate growth and differentiation of myeloid cells.
Nagamura-Inoue T; Tamura T; Ozato K
Int Rev Immunol; 2001 Feb; 20(1):83-105. PubMed ID: 11342299
[TBL] [Abstract][Full Text] [Related]
43. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
44. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
[TBL] [Abstract][Full Text] [Related]
45. A core erythroid transcriptional network is repressed by a master regulator of myelo-lymphoid differentiation.
Wontakal SN; Guo X; Smith C; MacCarthy T; Bresnick EH; Bergman A; Snyder MP; Weissman SM; Zheng D; Skoultchi AI
Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3832-7. PubMed ID: 22357756
[TBL] [Abstract][Full Text] [Related]
46. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN
Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091
[TBL] [Abstract][Full Text] [Related]
47. Pub, a novel PU.1 binding protein, regulates the transcriptional activity of PU.1.
Hirose S; Nishizumi H; Sakano H
Biochem Biophys Res Commun; 2003 Nov; 311(2):351-60. PubMed ID: 14592421
[TBL] [Abstract][Full Text] [Related]
48. Transcriptomic profiling identifies a PU.1 regulatory network in macrophages.
Weigelt K; Lichtinger M; Rehli M; Langmann T
Biochem Biophys Res Commun; 2009 Mar; 380(2):308-12. PubMed ID: 19167354
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1.
Minderjahn J; Schmidt A; Fuchs A; Schill R; Raithel J; Babina M; Schmidl C; Gebhard C; Schmidhofer S; Mendes K; Ratermann A; Glatz D; Nützel M; Edinger M; Hoffmann P; Spang R; Längst G; Imhof A; Rehli M
Nat Commun; 2020 Jan; 11(1):402. PubMed ID: 31964861
[TBL] [Abstract][Full Text] [Related]
50. Visualizing PU.1 activity during hematopoiesis.
Back J; Allman D; Chan S; Kastner P
Exp Hematol; 2005 Apr; 33(4):395-402. PubMed ID: 15781329
[TBL] [Abstract][Full Text] [Related]
51. The Ets family contains transcriptional activators and repressors involved in angiogenesis.
Lelièvre E; Lionneton F; Soncin F; Vandenbunder B
Int J Biochem Cell Biol; 2001 Apr; 33(4):391-407. PubMed ID: 11312108
[TBL] [Abstract][Full Text] [Related]
52. Zebrafish scl functions independently in hematopoietic and endothelial development.
Dooley KA; Davidson AJ; Zon LI
Dev Biol; 2005 Jan; 277(2):522-36. PubMed ID: 15617691
[TBL] [Abstract][Full Text] [Related]
53. The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.
Su GH; Ip HS; Cobb BS; Lu MM; Chen HM; Simon MC
J Exp Med; 1996 Jul; 184(1):203-14. PubMed ID: 8691135
[TBL] [Abstract][Full Text] [Related]
54. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
Dakic A; Wu L; Nutt SL
Trends Immunol; 2007 Mar; 28(3):108-14. PubMed ID: 17267285
[TBL] [Abstract][Full Text] [Related]
55. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
[TBL] [Abstract][Full Text] [Related]
56. Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity.
Kamath MB; Houston IB; Janovski AJ; Zhu X; Gowrisankar S; Jegga AG; DeKoter RP
Leukemia; 2008 Jun; 22(6):1214-25. PubMed ID: 18354487
[TBL] [Abstract][Full Text] [Related]
57. Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate.
Chou ST; Khandros E; Bailey LC; Nichols KE; Vakoc CR; Yao Y; Huang Z; Crispino JD; Hardison RC; Blobel GA; Weiss MJ
Blood; 2009 Jul; 114(5):983-94. PubMed ID: 19491391
[TBL] [Abstract][Full Text] [Related]
58. Protein expression and constitutive phosphorylation of hematopoietic transcription factors PU.1 and C/EBP beta in acute myeloid leukemia blasts.
Iida H; Towatari M; Iida M; Tanimoto M; Kodera Y; Ford AM; Saito H
Int J Hematol; 2000 Feb; 71(2):153-8. PubMed ID: 10745625
[TBL] [Abstract][Full Text] [Related]
59. Regulation of B lymphocyte and macrophage development by graded expression of PU.1.
DeKoter RP; Singh H
Science; 2000 May; 288(5470):1439-41. PubMed ID: 10827957
[TBL] [Abstract][Full Text] [Related]
60. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors.
Scott EW; Fisher RC; Olson MC; Kehrli EW; Simon MC; Singh H
Immunity; 1997 Apr; 6(4):437-47. PubMed ID: 9133423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
